Sentinel node biopsy in early breast cancer: Lessons learned from more than 1000 cases at a single institution

Tumori

Volumn 98, Issue 4, 2012, Pages 413-420

  Fancellu, Alessandro ^a   Cottu, Pierina ^a   Feo, Claudio F ^a   Bertulu, Daniele ^a   Giuliani, Giuliana ^a   Mulas, Silvia ^a   Sanna, Valeria ^b   Mura, Silvia ^a   Madeddu, Giuseppe ^a   Spanu, Angela ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b Neurology Unit   (Italy)

Author keywords

Axillary lymph node dissection; Early breast cancer; Sentinel node; Survival

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE EXTIRPATION; BREAST CANCER; BREAST CARCINOMA; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE FREE SURVIVAL; EARLY CANCER; FALSE NEGATIVE RESULT; FEMALE; FROZEN SECTION; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTRADUCTAL CARCINOMA; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; MACROMETASTASIS; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; METASTASIS; MICROMETASTASIS; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PREDICTIVE VALUE; PROSPECTIVE STUDY; SEGMENTAL MASTECTOMY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS; SURVIVAL TIME;

EID: 84867196308     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/030089161209800403     Document Type: Article

References (33)

1. Ollila DW, Brennan MB, Giuliano AE: The role of intraoperative lymphatic mapping and sentinel lymphadenectomy in the management of patients with breast cancer. Adv Surg, 32: 349-364, 1999.
2. Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S, Robertson C, Sacchini V, Veronesi P, Orvieto E, De Cicco C, Intra M, Tosi G, Scarpa D: Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst, 91: 368-373, 1999. (Pubitemid 29102337)
3. McIntosh SA, Purushotham AD: Lymphatic mapping and sentinel node biopsy in breast cancer. Br J Surg, 85: 1347-1356, 1998.
4. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM, Frazier TG, Noyes RD, Robidoux A, Scarth HM, Wolmark N: Sentinel-lymph-node resection compared with conventional axillary lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol, 11: 927-933, 2010.
5. Grube BJ, Giuliano AE: Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial. Semin Surg Oncol, 20: 230-237, 2001. (Pubitemid 32830834)
6. Giuliano AE, McCall LM, Beitsch PD, Whitworth PW, Morrow M, Blumencranz PW, Leitch AM, Saha S, Hunt K, Ballman KV: ACOSOG Z0011: A randomized trial of axillary node dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive sentinel node. 2010 ASCO Annual Meeting. J Clin Oncol, 28: 18s (abstr CRA506), 2010.
7. Peintinger F, Reitsamer R, Stranzl H, Ralph G: Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer, 89: 648-652, 2003. (Pubitemid 37076167)
8. Del Bianco P, Zavagno G, Burelli P, Scalco G, Barutta L, Carraro P, Pietrarota P, Meneghini G, Morbin T, Tacchetti G, Pecoraro P, Belardinelli V, De Salvo GL: Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial. Eur J Surg Oncol, 34: 508-513, 2008. (Pubitemid 351514885)
9. Zavagno G, Meggiolaro F, Bozza F, Scalco G, Racano C, Rubello D, Pescarini L, De Salvo G, Lise M: Sentinel lymph node biopsy in breast cancer: the GIVOM experience in Veneto, Italy. Tumori, 88: S52-54, 2002. (Pubitemid 34875483)
10. Dettori G, Madeddu G, Cottu P, Spanu A, Porcu A, Cossu- Rocca P, Fancellu A, Chessa F, Marras V, Scanu AM: Il ruolo del linfonodo sentinella nello staging ascellare. Proceedings of the 101st Congress of the Italian Society for Surgeons, Vol 3: 176-197, 1999.
11. Spanu A, Dettori G, Chessa F, Porcu A, Cottu P, Solinas P, Falchi A, Solinas ME, Scanu AM, Nuvoli S, Madeddu G: 99mTc-Tetrofosmin pinhole-SPECT (P-SPECT) and radioguided sentinel node (SN) biopsy and in breast cancer axillary lymph node staging. Cancer Biother Radiopharm, 16: 501-513, 2001. (Pubitemid 34024438)
12. Perry N, Broeders M, de Wolf C, Tornberg S, Holland R, von Karsa L: European guidelines for quality assurance in breast cancer screening and diagnosis, 4th edn. European Breast Cancer Network (EBCN): 329-331, Lyon, 2006.
13. Schüle J, Frisell J, Ingvar C, Bergkvist L: Sentinel node biopsy for breast cancer larger than 3 cm in diameter. Br J Surg, 94: 948-951, 2007. (Pubitemid 47236537)
14. http://www.ibcsg.org/Public/Health-Professionals/Closed-Trials/ IBCSG%2023-01/Pages/IBCSG23-01.aspx
15. Spillane AJ, Brennan ME: Accuracy of sentinel lymph node biopsy in large and multifocal/multicentric breast carcinoma-A systematic review. Eur J Surg Oncol, 37: 371-385, 2011.
16. Caudle AS, Hunt KK, Kuerer HM, Meric-Bernstam F, Lucci A, Bedrosian I, Babiera GV, Hwang RF, Ross MI, Feig BW, Hoffman K, Litton JK, Sahin AA, Yang W, Hortobagyi GN, Buchholz TA, Mittendorf EA: Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial. Ann Surg Oncol, 18: 2407-2412, 2011.
17. Shapiro-Wright HM, Julian TB: Sentinel lymph node biopsy and management of the axilla in ductal carcinoma in situ. J Natl Cancer Inst Monogr, 41: 145-149, 2010.
18. D'Eredità G, Giardina C, Napoli A, Ingravallo G, Troilo VL, Fischetti F, Berardi T: Sentinel lymph node biopsy in patients with pure and high-risk ductal carcinoma in situ of the breast. Tumori, 95: 706-711, 2009.
19. Intra M, Rotmensz N, Veronesi P, Colleoni M, Iodice S, Paganelli G, Viale G, Veronesi U: Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European Institute of Oncology on 854 patients in 10 years. Ann Surg, 247: 315-319, 2008. (Pubitemid 351156776)
20. Benson JR, Wishart GC: Is intra-operative nodal assessment essential in a modern breast practice? Eur J Surg Oncol, 36: 1162-1164, 2010.
21. Cserni G, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W, Borisch B, Connolly CE, Decker T, Dervan P, Drijkoningen M, Ellis IO, Elston CW, Eusebi V, Faverly D, Heikkila P, Holland R, Kerner H, Kulka J, Jacquemier J, Lacerda M, Martinez-Penuela J, De Miguel C, Peterse JL, Rank F, Regitnig P, Reiner A, Sapino A, Sigal-Zafrani B, Tanous AM, Thorstenson S, Zozaya E, Fejes G, Wells CA: Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol, 57: 695-701, 2004. (Pubitemid 38901482)
22. Yi M, Giordano SH, Meric-Bernstam F, Mittendorf EA, Kuerer HM, Hwang RF, Bedrosian I, Rourke L, Hunt KK: Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database. Ann Surg Oncol, 17 (Suppl 3): 343-351, 2010.
23. Grube BJ, Giuliano AE: Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial. Semin Surg Oncol, 20: 230-237, 2001. (Pubitemid 32830834)
24. De Boer M, van Dijck JA, Bult P, Borm GF, Tjan-Heijnen VC: Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases. J Natl Cancer Inst, 102: 410-425, 2010.
25. Maaskant-Braat AJ, van de Poll-Franse LV, Voogd AC, Coebergh JW, Roumen RM, Nolthenius-Puylaert MC, Nieuwenhuijzen GA: Sentinel node micrometastases in breast cancer do not affect prognosis: a population-based study. Breast Cancer Res Treat, 127:195-203, 2010.
26. Gobardhan PD, Elias SG, Madsen EV, van Wely B, van den Wildenberg F, Theunissen EB, Ernst MF, Kokke MC, van der Pol C, Borel Rinkes IH, Wijsman JH, Bongers V, van Gorp J, van Dalen T: Prognostic value of lymph node micrometastases in breast cancer: a multicenter cohort study. Ann Surg Oncol, 18: 1657-1664, 2010.
27. Van Zee KJ, Manasseh DM, Bevilacqua JL, Boolbol SK, Fey JV, Tan LK, Borgen PI, Cody HS 3rd, Kattan MW: A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol, 10: 1140-1151, 2003. (Pubitemid 40486808)
28. Veronesi P, Rodriguez-Fernandez J, Intra M: Controversies in the use of sentinel nodes: microinvasion, post surgery and after preoperative systemic treatment. Breast,16 (Suppl 2): S67-70, 2007.
29. Piñiero A, Giménez J, Vidal-Sicart S, Intra M: Selective sentinel lymph node biopsy and primary systemic therapy in breast cancer. Tumori, 96: 17-23, 2010.
30. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Maisonneuve P, Gatti G, Mazzarol G, De Cicco C, Manfredi G, Fernández JR: Sentinel-lymphnode biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol, 7: 983-990, 2006. (Pubitemid 44804136)
31. Giuliano AE, Chung AP: Long-term follow-up confirms the oncologic safety of sentinel node biopsy without axillary dissection in node-negative breast cancer patients. Ann Surg, 251: 601-603, 2010.
32. Cox C, White L, Allred N, Meyers M, Dickson D, Dupont E, Cantor A, Ly Q, Dessureault S, King J, Nicosia S, Vrcel V, Diaz N: Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy. Ann Surg Oncol, 13: 708-711, 2006.
33. Langer I, Guller U, Hsu-Schmitz SF, Ladewig A, Viehl CT, Moch H, Wight E, Harder F, Oertli D, Zuber M: Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients. Eur J Surg Oncol, 35: 805-813, 2009.